IPP Bureau
Novo Nordisk submits application to EMA for higher dose of Wegovy for obesity treatment
By IPP Bureau - July 09, 2025
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
Merck KGaA bestows 2025 Future Insight Prize to Helmholtz Center’s Magdalena Gotz for breakthroughs in brain regeneration
By IPP Bureau - July 09, 2025
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
BioMed X and Servier launch AI-powered antibody research at New XSeed Labs in Paris-Saclay
By IPP Bureau - July 09, 2025
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
IMCD opens life science laboratory hub in Shanghai
By IPP Bureau - July 09, 2025
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
Seeds of Innocence launches Asia’s first at-home IVF platform
By IPP Bureau - July 09, 2025
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
CARE Hospitals, Hitech City introduces AI-powered robotic surgery system
By IPP Bureau - July 09, 2025
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
OneSource Specialty Pharma appoints Jeffrey Wong as CBO
By IPP Bureau - July 08, 2025
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Duke Street Bio receives FDA fast track designation for PARP1-selective inhibitor with CNS activity
By IPP Bureau - July 08, 2025
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
AB Science receives FDA and EMA authorization for phase 3 Trial of prostate cancer treatment
By IPP Bureau - July 08, 2025
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Everest Medicines progresses in AI-powered mRNA platform at 2025 R&D day
By IPP Bureau - July 08, 2025
The company showcased three core programs developed through this platform
EMA and HMA to strengthen Anti-D Immunoglobulin supply chain
By IPP Bureau - July 08, 2025
These medicines are essential in preventing RhD immunisation during pregnancy
Veerhealth Care enters into contract manufacturing agreement
By IPP Bureau - July 08, 2025
Commercial production is expected to begin soon
Godavari Biorefineries' anti-cancer patent now validated in Spain and UK
By IPP Bureau - July 07, 2025
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Dr. Jitendra Singh inaugurates 'National Biobank' at CSIR-IGIB
By IPP Bureau - July 07, 2025
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
